Polymorphisms in Human MDR1 (P‐glycoprotein): Recent Advances and Clinical Relevance
C Marzolini, E Paus, T Buclin… - Clinical Pharmacology & …, 2004 - Wiley Online Library
Drug transporters are increasingly recognized to be important to drug disposition and
response. P‐glycoprotein, the encoded product of the human MDR1 (ABCB1) gene, is of …
response. P‐glycoprotein, the encoded product of the human MDR1 (ABCB1) gene, is of …
Multifactorial etiology of gastric cancer
J Zabaleta - Cancer Epigenetics: Methods and Protocols, 2012 - Springer
The prevalence of gastric cancer is associated with several factors including geographical
location, diet, and genetic background of the host. However, it is evident that infection with …
location, diet, and genetic background of the host. However, it is evident that infection with …
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant …
V Haufroid, M Mourad, V Van Kerckhove… - Pharmacogenetics …, 2004 - journals.lww.com
Cyclosporine and tacrolimus are immunosuppressive drugs largely used in renal
transplantation. They are characterized by a wide inter-individual variability in their …
transplantation. They are characterized by a wide inter-individual variability in their …
Implications of genetic polymorphisms in drug transporters for pharmacotherapy
R Kerb - Cancer letters, 2006 - Elsevier
Drug transporters are increasingly recognized as a key determinant of drug disposition and
response. It is now widely appreciated that expression of the ATP-dependent efflux …
response. It is now widely appreciated that expression of the ATP-dependent efflux …
Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms
K Kim, JA Johnson, H Derendorf - The Journal of Clinical …, 2004 - Wiley Online Library
Interethnic variability in pharmacokinetics can cause unexpected outcomes such as
therapeutic failure, adverse effects, and toxicity in subjects of different ethnic origin …
therapeutic failure, adverse effects, and toxicity in subjects of different ethnic origin …
Microparticles and their emerging role in cancer multidrug resistance
Drug resistance is a major obstacle to the successful treatment of cancer as tumor cells
either fail to reduce in size following chemotherapy or the cancer recurs after an initial …
either fail to reduce in size following chemotherapy or the cancer recurs after an initial …
An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients
Calcineurin inhibitors, tacrolimus (FK506) and cyclosporine (ciclosporin A), are the primary
immunosuppressive agents used on recipients of organ transplantations. The hepatic …
immunosuppressive agents used on recipients of organ transplantations. The hepatic …
Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs
OA Badary - The pharmacogenomics journal, 2021 - nature.com
The outbreak of Coronavirus disease 2019 (COVID-19) has evolved into an emergent global
pandemic. Many drugs without established efficacy are being used to treat COVID-19 …
pandemic. Many drugs without established efficacy are being used to treat COVID-19 …
MDR1 genotype-related pharmacokinetics: fact or fiction?
T Sakaeda - Drug metabolism and pharmacokinetics, 2005 - jstage.jst.go.jp
Multidrug resistant transporter MDR1WP-glycoprotein, the gene product of MDR1, is a
glycosylated membrane protein of 170 kDa, belonging to the ATP-binding cassette …
glycosylated membrane protein of 170 kDa, belonging to the ATP-binding cassette …
Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR‐1 …
DA Hesselink, T van Gelder… - Clinical …, 2004 - Wiley Online Library
Objective Our objective was to determine the relationship between single nucleotide
polymorphisms (SNPs) in the multidrug resistance 1 (MDR‐1) gene and the cytochrome …
polymorphisms (SNPs) in the multidrug resistance 1 (MDR‐1) gene and the cytochrome …